ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976